Taiwan · Delayed Price · Currency is TWD We Can Medicines Statistics
Total Valuation
TPEX:6929 has a market cap or net worth of TWD 1.05 billion. The enterprise value is 1.94 billion.
| Market Cap | 1.05B |
| Enterprise Value | 1.94B |
Important Dates
The next estimated earnings date is Friday, August 21, 2026.
| Earnings Date | Aug 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6929 has 45.09 million shares outstanding. The number of shares has increased by 94.75% in one year.
| Current Share Class | 45.09M |
| Shares Outstanding | 45.09M |
| Shares Change (YoY) | +94.75% |
| Shares Change (QoQ) | -0.95% |
| Owned by Insiders (%) | 0.64% |
| Owned by Institutions (%) | n/a |
| Float | 4.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.33 |
| PB Ratio | 1.04 |
| P/TBV Ratio | 1.05 |
| P/FCF Ratio | 3.72 |
| P/OCF Ratio | 3.29 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.04, with an EV/FCF ratio of 6.85.
| EV / Earnings | n/a |
| EV / Sales | 0.60 |
| EV / EBITDA | 8.04 |
| EV / EBIT | n/a |
| EV / FCF | 6.85 |
Financial Position
The company has a current ratio of 1.50, with a Debt / Equity ratio of 1.10.
| Current Ratio | 1.50 |
| Quick Ratio | 0.51 |
| Debt / Equity | 1.10 |
| Debt / EBITDA | 4.60 |
| Debt / FCF | 3.92 |
| Interest Coverage | -3.07 |
Financial Efficiency
Return on equity (ROE) is -7.40% and return on invested capital (ROIC) is -3.89%.
| Return on Equity (ROE) | -7.40% |
| Return on Assets (ROA) | -1.62% |
| Return on Invested Capital (ROIC) | -3.89% |
| Return on Capital Employed (ROCE) | -3.98% |
| Weighted Average Cost of Capital (WACC) | 1.35% |
| Revenue Per Employee | 3.14M |
| Profits Per Employee | -76,501 |
| Employee Count | 1,020 |
| Asset Turnover | 1.09 |
| Inventory Turnover | 2.56 |
Taxes
In the past 12 months, TPEX:6929 has paid 18,000 in taxes.
| Income Tax | 18,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.82% in the last 52 weeks. The beta is -0.61, so TPEX:6929's price volatility has been lower than the market average.
| Beta (5Y) | -0.61 |
| 52-Week Price Change | -27.82% |
| 50-Day Moving Average | 23.24 |
| 200-Day Moving Average | 28.50 |
| Relative Strength Index (RSI) | 53.30 |
| Average Volume (20 Days) | 7,706 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6929 had revenue of TWD 3.21 billion and -78.03 million in losses. Loss per share was -1.74.
| Revenue | 3.21B |
| Gross Profit | 1.05B |
| Operating Income | -75.97M |
| Pretax Income | -78.01M |
| Net Income | -78.03M |
| EBITDA | -10.01M |
| EBIT | -75.97M |
| Loss Per Share | -1.74 |
Balance Sheet
The company has 223.72 million in cash and 1.11 billion in debt, with a net cash position of -886.81 million or -19.67 per share.
| Cash & Cash Equivalents | 223.72M |
| Total Debt | 1.11B |
| Net Cash | -886.81M |
| Net Cash Per Share | -19.67 |
| Equity (Book Value) | 1.01B |
| Book Value Per Share | 22.58 |
| Working Capital | 449.58M |
Cash Flow
In the last 12 months, operating cash flow was 320.28 million and capital expenditures -37.33 million, giving a free cash flow of 282.95 million.
| Operating Cash Flow | 320.28M |
| Capital Expenditures | -37.33M |
| Depreciation & Amortization | 65.96M |
| Net Borrowing | -246.62M |
| Free Cash Flow | 282.95M |
| FCF Per Share | 6.28 |
Margins
Gross margin is 32.82%, with operating and profit margins of -2.37% and -2.43%.
| Gross Margin | 32.82% |
| Operating Margin | -2.37% |
| Pretax Margin | -2.43% |
| Profit Margin | -2.43% |
| EBITDA Margin | -0.31% |
| EBIT Margin | -2.37% |
| FCF Margin | 8.82% |
Dividends & Yields
TPEX:6929 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -94.75% |
| Shareholder Yield | -94.75% |
| Earnings Yield | -7.41% |
| FCF Yield | 26.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |